Saturday, 31st July 2010

   home     about     authors     news     books     xml feed     sitemap     privacy     contact us

There are 5 users online

add to favorites
 make home page


Books and Reading
 Business Education
 Business Industry
 Business Services and Assistants
 Business Technology
 Corporate Companies
 Current Events
 E-Commerce and Internet
 Economics
 Employment and Opportunities
 Finances
 International Business
 Investing
 Management Editorials
 Partnerships and Affiliate Programs
 Promotion and Marketing
 Seminars and Salesmanship
 Small/Home Business
 Statistics
 Tax Related
 The Stock Market
 Tips and Strategies
 Tools for Business

Our Newsletter

Sign up for our free
Business-Informant.com Ezine
Get all the latest Business News delivered right to your mailbox.

First Name:

Your Email:



We will never rent, share or sell your name to anyone else... ever! We respect your privacy!
  Other Resources


For other sources of business news, tips, and information, visit our resources page

 

  Submit an Article


Would you like to have your article posted?

More info on business issues
 

 
 
 
debt consolidation pic
sales pic
irs pic

Two Experts Take on Biotech: TheStockAdvisors.com Features John McCamant and Michael Shulman
Added: 06/26/2006
 Type: Tip
 Viewed: 632 time(s)
 [ Not Rated Yet ]
How would you rate this article:    Bad Good   Go » 
Two Experts Take on Biotech: TheStockAdvisors.com Features John McCamant and Michael Shulman

TheStockAdvisors.com (http://www.thestockadvisors.com), an interactive guide to financial newsletters announced today that it has provided readers with comments from two leading stock advisory groups. John McCamant and Michael Shulman comment on their outlook for two biotech companies BioCryst (BCRX: NASDAQ) and Genetech (DNA: NYSE).

When it comes to biotech stocks, few advisors have the long-standing expertise enjoyed by John McCamant. His success in finding opportunities among biotech stocks for his Medical Technology Stock Letter is based not just on analytic skills, but an in-depth understanding of the research underlying the sector, as well as direct contact and experience with researchers, analysts, venture capitalists, and executives in the sector.

Go direct to the full article: http://www.thestockadvisors.com/content/view/149/9/

"What is the most promising new technological or scientific approach as a long-term investment? The answer is personalized medicine -- including several trends currently in scientific development. Personalized medicine -- called ‘ME’ medicine -- is a very broad category of development categories and companies. The stocks in this emerging area are not yet in favor among institutional investors. The Street does not yet believe in most personalized treatments and this creates a great opportunity for us. Here, the editor of ChangeWave Biotech Investor looks at “the next great drug company.”

Go direct to the full article: http://www.thestockadvisors.com/content/view/55/9/

All readers on TheStockAdvisors.com receive free access to professional commentary and research from the top investing newsletters and their advisors.

TheStockAdvisors.com also offers a bi-weekly email which offers the best picks from the week’s posts. Subscribe for free at the sign-up box on our site: http://www.thestockadvisors.com

About TheStockAdvisors.com:

TheStockAdvisors.com is the first ever interactive site for individual investors and financial newsletter advisors. Steven Halpern, the editor of TheStockAdvisors.com, with his 24 years of experience as a financial newsletter editor, has set a goal to help investors learn from the most qualified, unbiased, and independent financial newsletter advisors.

We encourage users to actively participate in interactive forums, share feedback, and support our participating advisors. To subscribe to any of our featured newsletters, all names are conveniently linked to their respective websites.
Article Pages:  1  


credit pic
irs pic
debt consolidation pic

  Article Comments   Add Comment | View All (0)
    There are currently no comments for this article.


Advanced Search

More Resources

Become a Day Trader


Affiliate With Us
 


All content © 2010 Webmaster, Two Experts Take on Biotech: TheStockAdvisors.com Features John McCamant and Michael Shulman :: Business Articles and Info.